Xiaochun Zhang

机构：Nanjing University of Chinese Medicine, Second Affiliated Hospital of Nanjing Medical University · ORCID：0000-0002-5394-3091

发表论文 202 篇 · 总被引 6132 次 · h-index 40

代表论文

• MicroRNA-126 (MiR-126): key roles in related diseases (2024 · Journal of Physiology and Biochemistry · 被引 22)
• Accurate prediction of CDR-H3 loop structures of antibodies with deep learning (2024 · eLife · 被引 15)
• Effect of crosswind on the blowout limit of hydrogen-blended natural gas horizontal jet flame (2025 · Energy · 被引 12)
• Mid-Term Outcomes of K-Clip Transcatheter Tricuspid Annuloplasty System in Patients With Severe Functional Tricuspid Regurgitation (2024 · JACC: Cardiovascular Interventions · 被引 10)
• First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up of Chinese pts from CheckMate 649. (2025 · Journal of Clinical Oncology · 被引 7)
• Surgical procedure and recurrence of upper urinary tract stone: a national-wide study based on hospitalized patients (2024 · World Journal of Urology · 被引 7)